Evaluating the Short-Term Cost-Effectiveness of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Failing Metformin Monotherapy in the United States

BACKGROUND: Effective glycemic control can reduce the risk of serious micro- and macrovascular complications in type 2 diabetes. However, many patients fail to reach glycemic targets due partly to low efficacy and adverse effects of treatment such as hypoglycemia or weight gain. OBJECTIVES: To evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Langer, Jakob, Hunt, Barnaby, Valentine, William J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438006/
https://www.ncbi.nlm.nih.gov/pubmed/23537458
http://dx.doi.org/10.18553/jmcp.2013.19.3.237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438006/
https://www.ncbi.nlm.nih.gov/pubmed/23537458
http://dx.doi.org/10.18553/jmcp.2013.19.3.237

Ejemplares similares